Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.
about
Predictive factors of short term outcome after liver transplantation: A reviewType I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinomaClinical benefits of biochemical markers of bone turnover in Egyptian children with chronic liver diseases.Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma.Postoperative Insulin-Like Growth Factor 1 Levels Reflect the Graft's Function and Predict Survival after Liver TransplantationRapid identification of promoter hypermethylation in hepatocellular carcinoma by pyrosequencing of etiologically homogeneous sample poolsSerum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection.Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area.A survey of correlation between insulin-like growth factor-I (igf-I) levels and severity of liver cirrhosis.Circulating insulin-like growth factor-binding protein 3 as prognostic biomarker in liver cirrhosis.Insulin-like growth factor-I and the liver.Prognostic significance of insulin-like growth factor-I serum levels in acute decompensation of cirrhosis.Alterations of insulin-like growth factor I (IGF-I) and estradiol serum levels in chronic hepatitis C.Characteristics of adult patients with growth hormone deficiency who underwent neurosurgery for functioning and non-functioning pituitary adenomas and craniopharyngiomas.Serum prolidase and IGF-1 as non-invasive markers of hepatic fibrosis during four different periods after bile-duct ligation in rats.Insulin-like growth factor type 1 concentrations in hyperthyroid cats before and after treatment with thiamazole.Effects of administration of subtoxic doses of acetaminophen on liver and blood levels of insulin-like growth factor-1 in rats.Insulin-Like Growth Factor (IGF) System in Liver Diseases.
P2860
Q26741225-8D03167E-DB32-4722-9629-EBC1E0BB82CBQ28080514-68DF5A13-6401-4A89-8190-CF95A80527C0Q33788064-DB931261-249E-4A0A-BF65-0DD9B2A86FB0Q33859804-E51B3477-C459-492F-8172-BF912B0CA962Q35694770-0718F415-536A-4479-B353-E915805168C3Q35988103-11BE93F7-EE1E-4935-8834-CEC382E1A29DQ35995683-C38B75F9-6959-4D73-B410-CF9C8AC7CF83Q36255571-B1732646-241E-4CB4-9FC5-45419EB7BB83Q36770891-34288D39-12F8-410E-AE76-1EDE614C9BBAQ37014731-A903669B-562B-4769-B0A6-0D6D7172AECDQ37898184-B3C39B44-B0BA-4303-B262-4C1F02438DDBQ40520313-140EA036-1D45-4D23-9A52-3860BD0446E3Q42150842-DD59A8F6-02E0-4359-AF40-D9CE4585997EQ46485462-9E0B2CC2-B376-4817-A061-DBD4DF1B7405Q46902615-117978C8-C49B-4D65-89AA-87761C39677DQ47316445-436D870B-A9AC-4C27-8E65-382C55220985Q47878327-8AED6600-8D43-4C28-B05A-13B07E2FC47EQ52558393-55E58109-77DC-43E6-985C-BEB6DDB7F514
P2860
Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.
@ast
Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.
@en
type
label
Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.
@ast
Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.
@en
prefLabel
Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.
@ast
Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.
@en
P2093
P2860
P356
P1476
Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.
@en
P2093
P2860
P304
P356
10.3748/WJG.V10.I18.2740
P407
P577
2004-09-01T00:00:00Z